SEC Form 4 · accession 0001232524-15-000111
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth W O'Keefe
Director
Period of report
May 12, 2015
Accepted (ET)
May 14, 2015 · 8:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | May 12, 2015 | M | 4,500 | $46.83 | A | 10,650 | D | |
| Ordinary Shares | May 12, 2015 | S | 1,218 | $174.8978 | D | 9,432 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $46.83 | May 12, 2015 | M | 4,500 | D | — | Aug 8, 2022 | Ordinary Shares | 4,500 | 0 | D |
Explanation of responses
- F1The ordinary shares subject to this option fully vested as of August 9, 2013.